Although epilepsy surgery has met with increased interest in recent years it is still underused in most countries, particularly third-world countries. Possible reasons for the recent expansion in epilepsy surgery in the so-called developed countries include the availability of advanced non-invasive diagnostic tools to delineate epileptogenic lesions and epilepsy-related functional deficits. and to prove 'epileptogenicity'. Improved surgical techniques are, however, equally important. This translates into better postsurgical outcome figures and into a larger population of difficult-to-treat patients profiting from surgical therapy. There is, also. an important role for epilepsy surgery within the modem neuroscience field. A critical review and analysis of the present state-of-the-art epilepsy surgery is presented and possible scenarios for its future development are outlined. Within this framework the conceptual differentiation of epilepsy surgery into three categories-'lesion-oriented surgery', 'epilepsy-oriented lesional surgery' and 'epilepsy surgery SEXISTS srr-icro'-is maintained, since it is relevant to the organization of epilepsy centres. The growing need for quality control and multidiiciplinary and worldwide collaboration is emphasized.
INTRODUCTION
Until recently epilepsy surgery was considered by many to be a 'last resort' and only indicated in patients for whom 'nothing could be lost', despite the fact that modem epilepsy surgery dates back more than 100 years to when Macewen' and Sir Victor Horsley' initiated 'rationale' surgery in patients with epilepsy. Today epilepsy surgery is 'booming' in the so-called developed countries and there is increasing activity in third-world countries. What are the reasons for this boom? Is it justified on the basis of scientific medical data? What is the future of epilepsy surgery, both in the near future and beyond.
WHAT ARE THE REASONS FOR THE MASSIVE INTEREST IN EPILEPSY SURGERY?
First of all I believe in Hegelanian philosophical principles, which tell us that there is a sinusoidal fluctuation, i.e. an oscillation in opinions and related activi-ties. In the pioneering era of the founders of modem epileptology and related surgery, headed by Hughlings Jackson3 and Victor Horsley2, patients with gross underlying structural pathology were operated upon. There followed a second wave, starting on 12 March 1947, when Dr Percival Bailey4 performed the first of his series of anterior temporal lobe resections in a systematic attempt to treat 'non-lesional' psychomotor epilepsy. As early as 1938 Gibbs, Gibbs and Lennox had developed the notion of operating upon an electrical focus5. This became possible after the introduction of electroencephalography into epilepsy surgery by the joint efforts of Bailey and Gibbs4q6 in Illinois, Otfried Foerster and Altenburger in Breslau7-'o and Wilder Penfield and Herbert Jasper ' ' in Montreal. This secohd, enthusiastic wave of epilepsy surgery culminated in the outstanding work of the Montreal Neurological Institute and is enshrined in such books as Epilepsy and the Functional Anatomy of the Human Brain by Penfield and Jasper" which is still considered the standard in this field.
Falconer and his pupils must be given credit for standardizing and popularizing en bloc temporal lobectomy, which is still the most often performed epilepsy operation . '* After hemispherectomy was introduced as a neurosurgical procedure by Dandy in 192313 McKenzie14 and Krynauw" were the first to perform hemispherectomy for the treatment of epilepsy. Van Wagenen pioneered callosotomy in 1940t6* t7. This wave was associated with scrupulous documentation of the effects of ablative or interruptive epilepsy surgery on neurological and higher cognitive functions, as well as with intensified systematic research on the neuropathological and aetiological aspects of the epilepsies, and was paralleled by outstanding electrophysiological laboratory work.
The third wave may be characterized by the introduction into neurosurgery and presurgical evaluation of stereotaxic techniques: this era culminated in the pioneering work of Bickford, Flanigin, Crandall, Gloor and many others and, in particular, that of the Parisian St Anne group (Talairach, Bancaud, Szikla, and colleagues) which combines an exact three-dimensional neuroradiological examination of the brain under stereotactic conditions (rep&age) with stereotaxic depth recordings from many predetermined intracerebral targets with the scalp EEG, stereoelectroencephalography (SEEG; see'8-24). Although hindered by the fact that only a limited number of deep electrodes could be inserted on safety grounds (i.e. the 'sampling problem'), the era of SEEG undoubtedly clarified understanding of the relations between lesion, the epileptogenic zone and the 'irritative' zone, i.e. the area from which interictal epileptiform potentials were recorded. Moreover, the SEEG era prompted remarkable studies on the electroclinical semiology of seizures, including the propagation phenomena along preferential pathways, i.e. spatiotemporal aspects, and functional mapping of the available cortex and deep nuclear structures. This era of SEEG led to individually tailored epilepsy surgery. One of the obvious disadvantages of such an individual approach was difficulty in collecting and reporting on a large homogeneous series, since both the SEEG exploration and the resective surgery varied, to a large extent from patient to patient. The advantage was that each case almost always brought new insights in itself.
The recent new wave in epilepsy surgery is mainly the result of the advent of modem diagnostic methods, such as Magnetic Resonance Imaging (MRI) Positron Emission Tomography (PET) and Single Photon Emission Tomography (SPECT). Both 3iP-and ' H-MR-spectroscopy as well as Magnetoencephalography (MEG) are further remarkable developments and already widely used, although still considered 'experimental'25*26. The possibilities of refined structural and functional imaging are paralleled by the refinement of advanced telemetric long-term monitoring systems for simultaneous recording of a large number of EEG channels (and other neurophysiological parameters) and the behaviour of the patient, as well as by improved EEG analysis27.
The introduction of microsurgery has resulted in 'selective', i.e. more careful and refined, operations. The rationale for the introduction of microsurgical selective operations, such as 'selective amygdalohippocampectomy'28, was based on the results of refined presurgical evaluation protocols and, in particular, on SEEG findings. On the other hand, modem epilepsy surgery has witnessed a renewed interest in 'palliative' interventions, such as anterior callosotomy, a wider use of larger resections, such as subtotal functional hemispherectomy and extended multilobar resections, such as subtotal functional hemispherectomy and extended multilobar resections, particularly in children. The latter is the result of better knowledge of, and better diagnostic facilities in, certain childhood epilepsies29,30. In addition, new surgical techniques have been introduced, such as 'multiple subpial transsection'3'*32 and a few centres have started to explore the feasibility of radiosurgery (33-35; see also 8th International Meeting of the Leksell Gamma Knife Society, 22-25 June 1997, Marseille) for the treatment of certain epilepsies. Stereotactic interventions, which flourished for a time as a surgical treatment option in several countries, have now declined and are, with a few exceptions, no longer considered acceptable standard treatment procedures for epilepsies (for reviews see36-38).
Several special international epilepsy surgery meetings have taken place recently, and of these the two Palm Desert Meetings are the most noteworthy resulting in a number of comprehensive books39-4'. The International League Against Epilepsy (ILAE) has revitalized its Commission on Epilepsy Surgery. The recently published results of a search into the present state of epilepsy surgery around the world list surgery centres, their diagnostic and therapeutic facilities, personnel, number of operations and results4*. Moreover, the European Network of Surgically Active Epilepsy Centres has been active since 199243. During the 22nd International Epilepsy Congress in Dublin a position paper on standards and recommendations for epilepsy surgery was finalized by this Commission and will be published in the near future in Epifepsia.
GENERAL PRINCIPLES OF EPILEPSY SURGERY
Epilepsy surgery is an effective treatment for only some forms of epilepsy. It has been estimated that 20% of people with epilepsy have seizures that are not adequately controlled by antiepileptic medication, and that 50% of these patients are candidates for epilepsy surgery44*45. However, in the USA, of the 5000-10000 patients added annually to the lOOOOO-200 000 patients who would be considered candidates for surgical treatment, in 199 1 only 1500 surgical procedures were performed. There are two reasons why surgical treatment is envisaged for only one quarter of possible candidates for epilepsy surgery: (i) primary-care physicians remain unaware of the recent advances in both the safety and efficacy of epilepsy surgery; and (ii) third-party funders are reluctant to accept and pay for expensive new diagnostic and treatment approaches at a time when resources for health care are increasingly limited46.
Surgery for epilepsy is performed with either a 'causal' (= curative) or a 'palliative' indication. 'Causal' means that the goal of the operation is complete freedom from seizures, i.e. the intention is the complete resection of the seizure-generating area. 'Palliative' means that amelioration of the seizure tendency but no cure, is expected, because the seizuregenerating area is not resected. The resection of secondary 'amplifier structures' (as is the case in palliative amygdalohippocampectomy) or the transection of pathways important for the spread of seizure discharges (as is the case in callosotomy and multiple subpial transection) fall into the latter category. Epilepsy surgery can also be categorized into (a) lesion-oriented surgery (lesionectomy sense stricto), (b) epilepsy-oriented lesional surgery or (c) surgery for epilepsy SenSu micro. Finally it can be described under the category 'standardized interventions' (such as anterior temporal lobe resection, selective amygdalohippocampectomy, anterior callosotomy); and individually 'tailored interventions'. It is obvious that the 'standardized' operations are often also somewhat tailored, as they are based on preoperative findings as well as on intraoperative corticography and other intraoperative neurophysiological tests (functional mapping). Individually tailored operations comprise topectomies and larger resections.
PRECONDITIONS AND SELECTION CRITERIA FOR EPILEPSY SURGERY
The 'classical' selection criteria formulated by Walker in 197447 are still valid. In essence, however, they are criteria for resective surgery in adults. Modifications concern (a) the demand for early surgery, at least in certain epilepsy syndromes, such as the mesial temporal lobe syndrome; (b) 'palliative' surgery; and (c) a more liberal indication in children. For resective epilepsy surgery the following criteria have to be met: (i) the onset of focal or regional seizure, (ii) pharmaco-resistance, (iii) the seizures represent a severe handicap, (iv) the seizures have existed for a sufficient time (in general at least 2 years) to assess drug resistance, with no tendency to remission despite adequate medical treatment, (v) the patient has to have sufficient general and mental health to be sufficiently motivated and complaint in order to collaborate pre-, intra-(if necessary) and post-operatively.
Whether, and when, surgical treatment is advisable in individual patients, depends on the risks and benefits of surgical intervention. Surgically remediable syndromes, such as the syndrome of mesial temporal lobe epilepsy (MTLE) 4*-5' have been identified, i.e. it has been possible to define some specific syndromes, based on clinical features, seizure types and diagnostic test results that have a reasonably reliable surgical prognosis and, in some cases, a consistent pathophysiological substrate. Appropriate and timely referral of potential surgical candidates is a particularly important issue in those patients in whom 'curative' procedures can be envisaged, since relief of habitual seizures is not enough to permit acceptable psychosocial rehabilitation in patients who have been disabled by their disorder for many years. The main types of standardized epilepsy operations are now described. The very important presurgical evaluation procedures for candidates for epilepsy surgery is not dealt with in detail. The interested reader is referred to3gd'*52.
TEMPORAL LOBE SURGERY

Temporal lobectomy
There are currently two different approaches. The first, pioneered by the Montreal school, uses local and light general anaesthesia and allows a tailoring of the resection according to intraoperative stimulation and electrocorticography (cortical mapping). This approach is particularly important in neocortical temporal lobe epilepsies of the language-dominant hemisphere. The second approach is the standard anterior en bloc temporal lobe resection under general anaesthesia as popularized by Falconert2. About two-thirds of all epilepsy surgery procedures worldwide consist of temporal lobectomies. In the Montreal Neurological Institute (MNI) series this type of operation accounted for 56% of operations performed on 2177 patients between 1929 and 1980. There is no doubt that the exact borders of the removal have varied over time and from centre to centre. Initially the lateral temporal cortex was certainly more radically resected than the mesial structures. More recently, however, there has been a general trend to resect the mesial structures, i.e. the amygdala and hippocampal formation, more radically and to minimize lateral cortex resection53. In 'classical' anterior temporal lobectomy the posterior resection is usually at a distance of 5 cm (dominant hemisphere) to 7 cm (non-dominant hemisphere) from the pole, and the anterior hippocampus, at least the pes hippocampi, is resected.
The results of this operation performed worldwide in thousands of patients have been analysed over many years by Jensen54*55. According to her results 50-60% of patients have remained completely seizure-free and only 5-10% did not profit from this type of epilepsy surgery. For the period 1986-1990 Engel collected data on 4862 patients (from a total of 8234 epilepsy surgery cases) who underwent temporal lobectomy and reported that 68% of 3579 cases, after anterior temporal lobectomy and sufficient follow-up data, were seizure-free, 24% were 'improved', and 8% did not show any improvement56.
Although the success rates differ considerably from centre to centre, the more experienced centres now produce more homogenous results with respect to seizure outcome and also with regard to complications.
The overall mortality rate is less than 1% and in experienced centres it has decreased significantly over the years. For example, in a recent MN1 report no deaths occurred in the last 526 cases57. In a recent review by Pilcher et .f5* the following morbidity rates are given: transient and permanent hemiparesis occurred in 4% and 2% of cases respectively. A severe visual field defect (quadrantic, hemianopic) occurred in 24% of cases, but a mild defect (subquadrantic) occurred in more than 50% of cases. Infections and epidural hematoma were both observed in less than 0.5%, and a transient III nerve palsy occurred in less than 0.1%. Neurobehavioural post-operative deficits/complications were listed under the headings 'transitory aphasia' (>20%), 'persistent dysphasia' (l-3%), 'modality-specific memory deficits' (more severe following resection in the dominant (verbal) than in the non-dominant hemisphere), 'severe global memory deficits' (1%) and 'transitory psychosis/depression' (2-20%).
Selective amygdalohippocampectomy and related limbic temporal lobe resections
Based on our findings, that in the majority of temporal lobe epilepsy the mesiobasal limbic structures constitute the seizure-generating structures4*, we had argued as early as 1973 that in patients suffering from MTLE, the 'classical' anterior temporal lobe resection is too crude a surgical operation and the subsequent delineation of the recently described syndrome of mesial temporal lobe epilepsy (MTLE)24*5' confirmed our opinion. The need for a more selective resection of the mesiobasal limbic structure had been already proposed by Niemeyer as early as 195859. However, Niemeyer's transventricular approach was later abandoned. Selective amygdalohippocampectomy (AHE) with the trans-Sylvian approach was introduced in Zurich in 1975 for MTLE2* and has virtually replaced anterior temporal lobe resection in Zurich. At present AHE constitutes 66% of all epilepsy surgery performed in Zurich. At the second Palm Desert Conference on the Surgical Treatment of the Epilepsies it was reported that worldwide a total of 548 AHEs were performed during the period 1986-199056.
Today the Zurich AHE series comprises 354 patients. More males (56%) than females (44%) have been operated on. The AHE was on the right in 51% and on the left in 49%. The mean age at onset of epilepsy was 17.8 (SD 14.8) years, the mean pre-operative duration of seizure illness was 13.1 (SD 11.1) years, and the mean age at surgery was 30.9 (SD 13.5) years. From the underlying neuropathology we grouped AHE patients into seven histologic classes: benign (n = 38), semibenign (n = 64), and malignant (12 = 55) tumours; vascular malformations (n = 38); gliosis (ir = 112); other, mainly dysontogenetic lesions (n = 13); and no microscopic pathology (77 = 34).
The post-operative seizure outcome was classified into Engel'&" four categories: I = seizure-free; II = rare seizures (not more than two per year); III = worthwhile improvement (290% seizure reduction and significant improvement in quality of life); and IV = no worthwhile improvement. A follow-up of at least 1 year was required: outcome classification was possible in 283 patients at the end of 1995. The yearby-year seizure outcome for the Zurich AHE series is given in Table 1 and Fig. 1 .
At the second Palm Desert Conference outcome data were available for 413 patients worldwide who had had AHE within the period 198690. The following numbers were reported: seizure-free, 68.8%; 'improved', 22.3%; and 'not improved', 9.0%56.
In conclusion MTLE is a surgically amenable epilepsy syndrome, which can be operated on without invasive monitoring, if findings of non-invasive evaluation are fully concordant. Preconditions are: generalization of seizures. It should be considered in pharmaco-resistant epileptic conditions where no circumscribed cortical excision is possible because of extended poorly localized epileptogenic seizuregenerating zone(s); ictal EEG findings are, however, lateralized with rapid generalization (so-called 'secondary bilateral synchrony'). Clinically, candidates for callosotomy usually suffer multiple seizure types, but those with severe sudden falls are said to respond best to this surgical approach. Section of the corpus callosum can either be partial or complete; in the latter, it is usually done in two stages, i.e. an anterior callosotomy (the anterior two-thirds to three-quarters of the corpus callosum) is completed at a second stage, if necessary. Great care is necessary to preserve the parasagittal veins. Damage of the frontal interhemispheric cortex by retraction must be avoided. It should not be expected that callosotomy will render a patient seizure-free. It is by nature a 'palliative' procedure and aims to prevent secondary generalization of the seizure. However, from the available literature68-72 5-10% of patients are reported to become seizure-free, and 65-75% are significantly improved with at least a 50% reduction in seizure frequency, while 20% are unimproved. As expected the results of callosotomy are different for different seizure types. Atonic seizures respond best (with 70-75% improvement with at least a 50% seizure reduction) compared to absence attacks and complex partial seizures (with 35-60% improvement). It is important to know that partial seizures can worsen following callosotomy. From Wyler's series67 no clear-cut conclusions can be drawn with regard to IQ and seizure outcome. Complications associated with anterior callosotomy are usually transient and consist of postoperative dysfunction of speech and hemiparesis or apraxia of the limbs opposite to the side of operation. Complete callosotomy induces a 'disconnection syndrome' characterized by mutism, a left-sided apraxia resembling hemiparesis, and bilateral frontal lobe reflexes. Interhemispheric sensory dissociation is seen only after posterior section, whereas the 'alien hand syndrome' might be seen after an extended threequarter anterior section. Even if easily seen a disconnection syndrome rarely represents a significant handicap in daily life for patients who have profited epileptologically from this type of epilepsy surgery.
Mutism is most commonly a consequence of excessive retraction of the frontal lobe. It can be reduced by positioning the patient in the lateral decubitus position and using spinal drainage.
Multiple subpial transection
In 1969 Morrell and Hanbrey3' proposed an alternative surgical technique, termed 'multiple subpial transection' (MST), for non-resectable epileptic foci localized in a highly functional cortical area, such as primary motor cortex or language areas. MST consists of perpendicular multiple transections of one gyrus or more, using a specially shaped instrument. The transections are separated by -5 mm. Morrell proposed that this approach had the potential of improving the epilepsy by preventing horizontal seizure spread without inducing significant functional deficits because the vertical connections of the transected cortex would be preserved. In 1989, Morrell and colleagues3* presented the results of the procedure on 32 cases and concluded that MST was about as effective as standard cortical resection. In many of the cases reported by Morrell and colleagues3* and in subsequent reports MST was associated with cortical resection, hence judging the effectiveness of MST is difficult. MST has also been performed in the Landau-KIeffner syndrome to prevent progression or to ameliorate aphasia thought to be of epileptogenic origin (for review see73). MST is still under evaluation, but a recent report on seven cases of pure MST without associated cortical resection suggests that MST might be a worthwhile 'palliative' surgical procedure in certain well selected cases suffering from pharmaco-resistant partial epilepsy localized in a highly functional cortical area74.
Stereotactic procedures
Epilepsy surgery stereotactic interventions were more frequent but are no longer today practised in centres of excellence. Review of the existing literature suggests that it is impossible to judge the efficacy of these procedures (very often performed with various combined targets)36* 37. Stereotactic interventions fall into the category of 'palliative' epilepsy surgery and attempt to interrupt seizure spread along known pathways of discharge propagation. Into this group fall fomicotomies (the fornix is the only efferent pathway from the hippocampus) and some thalamotomies and the Forel-H-tomy 75. Stereotactic amygdalotomy might be indicated in the extremely rare amygdala onset epilepsies38T76. Amygdala epilepsies constitute no more than 3-5% of all temporal lobe epilepsies in our stereo-EEG explored patients.
Other experimental procedures or epilepsy surgical techniques under evaluation
Into this category fall intermittent vagal stimulation" and attempts to transplant foetal or genetically engineered inhibitory active cells into the epileptogenic focus'*.
A REALISTIC VIEW OF THE OUTCOME DATA OF EPILEPSY SURGERY: IS THE 'BOOM' JUSTIFIED?
The answer to this question is neither easy nor simple: comparing recently published surgical outcome data with previous data stemming from 'older' surgical series suggests that progress has been made: postoperative seizure-outcome nowadays seems to be better. However, these better seizure-outcome figures do not reflect the whole truth. First of all comparable outcome data are only available from renowned centres and not from the many 'newcomers' in this field. It could be argued that the results of less experienced groups are inferior to those of long established centres with a high international reputation. Moreover, the reported results are significantly better only in certain areas, such as temporal lobe surgery and even here, despite all progress, the overall seizure-free rate is no higher than 73% (far below 100% seizure freedom).
It can be argued that today a more difficult population is accepted for surgery than previously, and therefore results reported for series have not dramatically improved. The relatively few long-term results4g*60*7g* *' clearly show that even in centres of excellence late outcome data reflect a more realistic view. A considerable number of surgical patients experience recurrence of seizures60* *' and/or significant deficits in higher cortical functions. Thus the ongoing studies of many centres (which are preparing their late outcome results, including quality-of-life measures) might give us a more 'realistic' picture of what epilepsy surgery can really do and will prevent over-enthusiastic extrapolation of short-term followup reports. The picture in non-lesional extratemporal surgery is even more realistic. Most centres had to learn that the overall results in extratemporal surgery remain inferior to those of temporal lobe epilepsy and that without a lesion the results in extratemporal epilepsy surgery are relatively. poor. The main progress, however, lies in the fact that today highresolution MRI can detect lesions, if present, with high sensitivity. Thus it may be expected that the outcome of surgery in extratemporal epilepsies, when based on structural abnormalities, will improve significantly. Despite these somewhat cautious remarks, in general I believe that there has been an improvement in epilepsy surgery. Positive progress can certainly be seen in the following areas: modem diagnostic methods have made presurgical evaluation much less invasive and thus more suitable for a larger group of medically difficult-to-treat patients. There is an improvement in both selection of candidates for surgical treatment and refined indications for different surgical treatments. There is considerable improvement in precision with regard to the localizational aspects of epilepsy surgery. Surgical outcome can be more reliably predicted if modem diagnostic methods, such as selective Amytal test@', functional MRI**, and probably 'functional' PET83 are available. There is considerable progress in identifying surgically remediable epilepsy syndromes without resorting to risky and costly procedures with MTLE being the best example. There is also improvement in surgical techniques including anaesthesia and localization. Besides these clinical aspects, which are, of course, very important, there are the scientific aspects allied to epilepsy surgery to be considered. These include two main areas: the first concerns a better understanding of the underlying pathophysiological causes of the various types of epilepsies and is directly related to prevention and treatment. The second deals, in a more general manner, with the knowledge of how the human brain functions and particularly its functional organization. Epilepsy remains a true 'window to the brain' and gives insights into 'the mystery of the mind'84. The data emerging from a comprehensively exploited and hopefully successfully operated single patient offer unique possibilities to unravel the mysteries of how the brain functions under certain conditions. This, however, demands minute documentation of pre-and post-operative findings (including the difficult-to-measure higher cortical functions) which might show characteristic changes in response to surgical treatment. The correlation of the results of histopathologically examined brain tissue with clinical and paraclinical data, in particular seizure semiology, EEG, neuropsychological, MRI-, 'H-MRS-, PET-and SPECT-data, is a unique opportunity for neuroscience in general and for future development, as well as for the validation, of newly available diagnostic techniques. In fact it might not be an overstatement to say that epilepsy surgery programmes today are already one of the driving forces behind and fundamental to much progress in the neurosciences. In order to maintain and improve this comprehensive stimulating role of epilepsy surgery within the scenario of modem neurosciences a thoroughly scientific utilization of the date stemming from epilepsy surgery programme is necessary. In my opinion much remains to be done in this respect to improve the present situation, in particular with a view towards the collection of prospective computerized data, their interdisciplinary utilization, and careful follow-up studies.
What is the likely and speculative future of epilepsy surgery?
With regard to the number of 'reference centres' it is anticipated that the 'boom' in epilepsy surgery has reached a plateau in many so-called developed countries. Shortage of health-care resources, on the one hand, and the need for extremely multifaceted and interdisciplinary work on the 'difficult' epilepsy patients, on the other hand, will limit the growth of 'reference centres'. The further development of the latter asks for a high-standard multidisciplinary university environment with the availability of various specialists: epileptologists, electroencephalographers, neurologists, neurosurgeons, neuroanaesthesists, neuropsychologists, neuroradiologists and neuropathologists, mathematicians for advanced EEG analysis (such as non-linear analysis ['chaos-theory'] and source localization [dipole mapping]), specialists in informatics for advanced long-term telemetric monitoring, the installation and administration of data banks and data analysis, biophysicians for the development of fMR and MRS82*85 and with a view towards better editing of inhibitory and excitatory neurotransmitters8"88, biochemists for the development and supply of new PET tracers , such as Hz"0 18F-FDG Flumazenil, as well as SPECT tracers, su:h as Technetium 99m-hexamethyl-propylenamin oxime (ggmTc-HMPAO), Technetium-99m ethyl cysteinate dimer (ggmTc ECD) and ['231]Ro43-0463, a recently developed MAO-B inhibitor8g and many othersgo*". The need for the availability of such a rich multidisciplinary team is certainly a limiting factor for the creation of more new well equipped 'reference centres'. It asks for a university environment, which cannot be easily provided 'from scratch'. On the other hand, since more and more surgically remediable epilepsy syndromes that do not need invasive and extremely costly presurgical work have been identified, it is anticipated that these 'easy' patients will be operated inwhat the ILAE Commission on Neurosurgery callsBasic Epilepsy Centres, and that the number of this type of centre with limited facilities will grow both in the so-called developed countries and third-world countries. This anticipated development must be welcomed from the perspective of patients seeking help. It is, however, not unproblematic for several reasons. First it will deprive the highly-developed reference centres of the 'easy' and less costly patients who by their very nature offer a good success rate following surgery and will leave them with the more 'difficult' and demanding patients that will show less good results. In turn a centre with declining success rates will certainly lose its reputation and support and therefore run into problems. Secondly there is a danger that Basic Epilepsy Surgery Centres will overestimate structural MRI findings-and underestimate electrophysiological and other functional tests, with the danger that epilepsy surgery will step backwards to 'lesional surgery'. This will stop the independent evolution of epilepsy surgery and bring it closer to general neurosurgery. Although for many extratemporal epilepsies and even for MTLE future research will probably show that such an attitude is appropriate, at present the issue of 'lesional surgery' versus epilepsy surgery, i.e. removal of the 'epileptogenic' seizure onset zone and the lesion (where present) is not entirely resolved and further research is needed to reach firm conclusions. In addition, it is not too difficult to anticipate that Basic Epilepsy Centres will have difficulties in scientifically documenting and reporting their data and guaranteeing highlevel follow-up studies because of the usually heavy burden of clinical duties in addition to limited resources. The ILAE Commission on the Neurosurgery of Epilepsy therefore proposed that Basic Epilepsy Centres should restrict epilepsy surgery to those areas in which they are competent and that they should collaborate intimately with 'Reference Centres' in order to maintain high quality. Furthermore it was suggested that 'experimental surgical procedures' should only be performed at centres which have access to the entire range of accepted diagnostic and therapeutic procedures. In this way it is hoped that the indication for and the evaluation of 'experimental procedures' will be under better quality control. At present, third-world countries suffer heavily from the underuse of epilepsy surgery and it is mandatory to improve this situation by creating epilepsy surgery centres that concentrate on 'easy' patients without demanding a sophisticated and costly work-up. The ILAE Commission on the Neurosurgery of Epilepsy therefore sees an urgent need for adequate training and educational programmes with the prospect for intimate collaboration between established epilepsy surgery centres and 'newcomers' in third-world countries. Both the ILAE with its Commissions and European Initiatives, such as the recently founded European Academy for Epileptology (EUREPA), are making strong efforts in this direction. Since epilepsy surgery remains in its essence a 'mutilating' treatment, we should not abandon the search for better forms of treatment. Can epilepsy surgery be replaced by better ways of treatment in the distant future?
The introduction of several 'new' antiepileptic drugs (AEDs), such as vigabatrin, lamotrigine, gabapentin, topiramate, oxcarbazepine and felbamate in most countries and the anticipated marketing of levotiracetam (ucb LO59), zonisamide and other drugs in some countries, raise expectations of improved drug treatment for the epilepsies. Whilst it is undisputed that these new AEDs do have advantages over the classic AEDs, particularly with respect to fewer side effects, the overall number of patients considered to be candidates for epilepsy surgery who would become seizure-free after the use of these new AEDs is negligibly small, (i.e. it ranges below 2-3%). Thus newly available AEDs have not affected the practice of epilepsy surgery until now.
There is hope that the prediction of seizures might advance with the advent of sophisticated online EEG analysis, using the methods of non-linear dynamics92-94. Until now, however, positive results in this respect were derived only from intracranial, i.e. SEEG and foramen ovale electrodes, recordings. Behavioural therapy as the theoretically most elegant therapy should not be ignored in this context. Once again, until now, despite remarkable results95, there is no indication that it will significantly affect the number of candidates for epilepsy surgery.
Thus the forecast for the near future of epilepsy surgery indicates that it will not decline. On the contrary, it is reasonable to assume that it will show an overall growth in a more than linear fashion, but with a plateau for the so-called Reference Centres in developed countries. The distant future of epilepsy surgery is difficult to predict. It is my guess that advances in genetics and in gene therapy will ultimately allow a time-and/or localization-specific therapy for many epilepsy patients to be developed. Surgical techniques might change from open classical neurosurgery and open microsurgery to 3D stereotactic guided microsurgery and MRI-guided gamma knife radiosurgery and stereotactic radiosurgery with linear accelerator (LINAC) beams. Brain modelling by structural and functional data fusion is already used in advanced operating theatres (for review of these techniques see96). Implantation of genetically engineered inhibitory cells into the 'focus' may become an option .
78 Identification of candidates for certain surgical treatments will be possible without resorting to invasive methods and will be paralleled by increased knowledge of the pathological mechanisms underlying the generation of seizures. Prediction of surgical outcome will advance by non-invasively differentiating 'indispensable cortex' from functionally inert and irreversibly damaged cortex. Surgical precision will increase. All this will theoretically allow for better research which will ultimately feed its results back for better clinical treatment options. However, as in other fields, the future development of epilepsy surgery will depend on the high-quality work of highly motivated persons who are willing to struggle life long for the needs of their patients, devoting their lives to highquality clinical work as well as high-quality clinical and experimental research in an environment where the Hippocratic principles are not pushed away by inhuman and unethical short-lived egoistic goals and fights for surviva197. It is my deeply held belief that in epilepsy surgery the realization of Wilder Penfield's lifelong and successfully followed principle that 'no man [should be] alone'98 is the ultimate key to further progress in this field. Governments and health-care providers should help to realize and maintain optimally functioning epilepsy surgery centres of excellence in order to guarantee the maintenance of highquality work and to foster further progress in this area.
CONCLUDING REMARKS
Epilepsy surgery is playing an increasingly important role in the epileptologist's therapeutic armoury. In part this is due to the considerable improvement in structural and functional imaging and electrophysiological techniques, particularly long-term EEG monitoring. It is also due to a better understanding of the pathophysiology of those epileptic disorders which are amenable to surgery, and refinements in surgical techniques. Today reasonably reliable prognosis can be made prior to the recommendation for surgery based on inclusion and outcome data collected worldwide. Whereas careful and knowledge-able presurgical evaluation of candidates for epilepsy surgery still remains the most important step, there is no doubt that today a considerable number of patients can undergo successful surgery without invasive intracranial presurgical procedures, resulting in improved cost-effectiveness and in a growing utilization of this type of therapy in countries with limited resources. Whereas for years epilepsy surgery has been considered a 'last resort' by many doctors, surgical treatment for epilepsy is nowadays an evolving and accepted discipline. It is hoped that the resulting growth in basic research on the epileptic human brain and improved surgical techniques will result in further improvement in the treatment of certain types of epilepsy. On the other hand, experience shows that quality control in epilepsy surgery is very important. Worldwide collaboration and the establishment of national centres of reference for epilepsy surgery are probably the best way to guarantee the attainment of high and acceptable standards. 
